Net Income (Quarterly) Chart

View Net Income (Quarterly) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -15.15M
March 31, 2026 -18.97M
December 31, 2025 -14.14M
September 30, 2025 -14.02M
June 30, 2025 -9.289M
March 31, 2025 -10.81M
December 31, 2024 -8.802M
September 30, 2024 -12.11M
June 30, 2024 -10.38M
March 31, 2024 -7.666M
December 31, 2023 -11.27M
Date Value
September 30, 2023 -5.649M
June 30, 2023 -7.729M
March 31, 2023 -10.94M
December 31, 2022 -16.59M
September 30, 2022 -0.441M
June 30, 2022 0.334M
March 31, 2022 -5.763M
December 31, 2021 -4.091M
September 30, 2021 -1.837M
June 30, 2021 -2.125M
March 31, 2021 -1.149M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Atai Beckley, Inc. -32.55M
Avadel Pharmaceuticals Plc 0.02M
Jazz Pharmaceuticals Plc 192.80M
Eli Lilly & Co. 7.095B
Perrigo Co. Plc 88.50M

Net Income (Quarterly) Related Metrics